Clin2
NCT04356755Possibly a fitRecruiting

Injections under the skin to heal scleroderma finger ulcers

Systemic Sclerosis

Treatments studied

Part of Skin clinical trials.

This Phase 2 study tests whether injections under the skin can help heal painful, poor-circulation (ischemic) finger ulcers caused by scleroderma. It is for people whose ulcers have not improved with usual care.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
32 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are age 18 or older and have systemic sclerosis (scleroderma)
  • You have at least one active, painful finger ulcer from poor circulation that is not healing despite standard treatment for about 10 weeks
  • The ulcer is on the finger past the first knuckle (near the nail is allowed) and is not from bone/calcified areas
  • You should not be a current smoker, and you must not have stopped tobacco less than 3 months ago
  • Your medicines must be stable or paused as required (especially hormone therapy, blood-vessel medicines, immune medicines, steroids, and antibiotics)
  • You cannot have certain infections or serious heart/virus conditions, and you must be able to give written consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03211793Recruiting· Phase 1/Phase 2
Cell treatment for painful hand sores in systemic sclerosis

This trial tests a cell-based treatment (mesenchymal stromal cells) to help heal painful finger/toe ulcers in people with systemic sclerosis. It is for ulcers that did not improve after a specific IV medicine called prostacyclins.

Utrecht
NCT07697274Not yet recruiting· Early Phase 1
Hyaluronidase for finger stiffness in scleroderma

This trial tests whether an injected enzyme called hyaluronidase can soften and loosen tight skin on the fingers caused by scleroderma, which may improve flexibility and comfort.

Charleston, South Carolina
NCT06489652Not yet recruiting· Phase 1
Cell therapy for scleroderma

This early-stage trial tests an investigational cell therapy for people with systemic sclerosis (scleroderma). The treatment uses your own modified immune cells to try to calm the overactive immune system and slow the disease, with imaging to see where the cells go in your body.

NCT06058091Recruiting· Phase 1/Phase 2
Cell injection therapy for systemic sclerosis

This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.

Nanjing, Jiangsu
NCT06954597Recruiting· Phase 2
Testing a new cream for scleroderma finger ulcers

This study tests a new cream (TOP-N53) for digital ulcers caused by scleroderma. The cream is applied directly to the sore, and the goal is to see if it is safe and helps the ulcer heal.

Bordeaux
NCT06256575Recruiting
Diosmin for healing finger ulcers in scleroderma

This study tests whether a natural supplement called diosmin can help heal finger and toe ulcers in people with scleroderma. If you have a current ulcer that is not infected, you may be able to join.

Calgary, Alberta

Hear when a new Systemic Sclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.